Skip to main content

Table 4 Quality of Life Questionnaire for Patients with Prostate Cancer (EORTC QLQ-PR25)

From: 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment

EORTC QLQ-PR25

Baseline (Mean ± SD)

Post-Rt (Mean ± SD)

p

Urinary Symptoms

10.2 ± 3.1

10.3 ± 3

0.21

Incontinent Aid

1.1 ± 0.5

1.1 ± 0.5

1

Bowel Symptoms

4.3 ± 0.6

4.5 ± 1.8

0.33

Hormonal-treated Related Symptoms

6.9 ± 1

6.8 ± 1.2

0.19

Sexual Activity

3.2 ± 1.7

3.2 ± 1.5

0.71

Sexual Functioning

7.2 ± 4

6.3 ± 3.4

0.76